-
The US Food and Drug Administration (FDA) has authorised the use of a new test to diagnose humans infected with the 2009 H1N1 influenza virus (formerly known as swine flu or pandemic H1N1 flu).
26/07/2010 |
-
Asuragen and Life Technologies have commercially launched in Europe the BCR/ABL1 Quant Test, which is intended to aid clinicians in monitoring and treating individuals afflicted with chronic myeloid leukaemia (CML).
26/07/2010 |
-
Australian researchers have begun clinical trials of a new vaccine to protect newborn infants against rotavirus.
26/07/2010 |
- October 17
- HAA2010
SkyCity Convention Centre, Auckland, New Zealand
Enquire now
Visit website
Enquire now
Visit website